LONDON, June 20, 2017 /PRNewswire/ -- Highlights
Download the full report: https://www.reportbuyer.com/product/4946496/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
Advertisement
- The global radiodermatitis market is expected to reach USD 442.1 million by 2025, according to a new report by Grand View Research, Inc.
- The global radiodermatitis market is expected to grow at an unprecedented rate owing to the growing prevalence of cancer patients undergoing radiation therapy.
- The demand for radiodermatitis treatment is also accentuated by unmet medical needs of consumers in emerging as well as developed regions.
- ncreasing focus of government healthcare organizations for promoting awareness about available treatment products for radiodermatitisis predicted to present the market with high potential growth opportunities.
- This agreement was carried out to reinforce its position as a prevention solutions firm.
- In addition, they have signed a joint agreement to enhance their R&D capabilities and commercialize new patented technological platforms.
Advertisement
Download the full report: https://www.reportbuyer.com/product/4946496/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/radiodermatitis-market-is-expected-to-reach-usd-4421-million-by-2025-300477079.html
SOURCE ReportBuyer